Business Wire

WHOOP Names Dirk-Jan "DJ" van Hameren Chief Marketing Officer as Member Base Surpasses 3 Million

8.7.2026 13:00:00 CEST | Business Wire | Press Release

Share

WHOOP, the human performance company, today named Dirk-Jan "DJ" van Hameren as Chief Marketing Officer. The appointment comes as WHOOP surpasses 3 million members worldwide after adding its latest one million members in just seven months. The former Nike Global Chief Marketing Officer and two-time Olympian joins WHOOP to help build the world's defining global brand for human performance and proactive health.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708877245/en/

WHOOP Names Dirk-Jan "DJ" van Hameren (left) Chief Marketing Officer as Member Base Surpasses 3 Million

Van Hameren spent more than three decades at Nike, where he rose from the mailroom at the company's European headquarters to become one of the most influential marketing leaders in the world. He served as NIKE Inc.’s Executive Vice President and Chief Marketing Officer, leading Nike's worldwide marketing organization.

Van Hameren joins WHOOP as the company enters a period of unprecedented acceleration. Over more than a decade, WHOOP has earned the trust of the world's highest-performing athletes by helping them understand, train, and improve their performance. Today, WHOOP is bringing that same performance mindset to millions of people who want to live longer, healthier, higher-performing lives.

That momentum is reflected in the company's growth. WHOOP recently surpassed 3 million members worldwide after adding its latest million members in just seven months. International membership has grown more than 11x since January 2023, and today 58% of members live outside the United States. WHOOP is also reaching a broader audience than ever before, with teen membership growing more than 10x since January 2023, women's membership more than doubling over the past year, and membership among adults over 60 increasing more than 130% year over year.

"The next great health company will do more than deliver breakthrough technology,” said Will Ahmed, Founder and CEO of WHOOP. “It will also inspire people to take control of their health every day. DJ has spent his career building brands that shape culture and motivate millions of people, and I'm excited for him to bring that experience to WHOOP.”

At WHOOP, van Hameren will lead global marketing across brand, creative, international markets, media, athlete and sports partnerships, and product storytelling. He will help further expand WHOOP as a brand rooted in sport, trusted in health, and embraced by people committed to reaching their full potential.

"What attracted me to WHOOP was the scale and importance of the opportunity,” said van Hameren. “The company has earned extraordinary credibility with elite athletes and built an incredibly engaged, global community of more than three million members. But I believe we're still at the very beginning. Proactive health will become one of the defining categories of our generation. WHOOP will build the global brand that defines it."

Before becoming Nike's Chief Marketing Officer, van Hameren served as Global Vice President and General Manager of Nike Sportswear, where he led $7 billion of Nike Sportswear revenue growth and helped drive the success of iconic franchises including Air Max, Air Force 1, and Tech Fleece. During his tenure at Nike, he also led the ideation and execution of the Livestrong initiative, the award-winning "Dream Crazy" campaign, and the company's global marketing for the 2004, 2012, and 2024 Olympic Games. Prior to his business career, van Hameren represented the Netherlands as a track cyclist at the 1992 Barcelona and 1996 Atlanta Olympic Games.

Van Hameren has been recognized by Campaign US CMO 50 and Forbes' World's Most Influential CMOs. After leaving Nike, he co-founded Superconnector Sports, launched his advisory firm, Mailroom Marathon 7, and serves as an Operating Advisor to Arctos Partners.

For more information on WHOOP and its latest health innovations, visit whoop.com.

A digital press kit containing executive photography, company fact sheet, executive biographies, logos, and additional media assets is available here.

About WHOOP

WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, get over two extra hours of sleep, and have 10% higher heart rate variability.

Trusted by millions of members worldwide—including athletes, global leaders, military operators, executives, and artists—WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $900 million in venture capital, ships to 56 countries, and operates in six languages. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260708877245/en/

Contacts

Media Contact
Jack Taylor Worldwide
whoop@jacktaylorpr.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Cardiac Dimensions ® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour System ®8.7.2026 16:05:00 CEST | Press Release

Cardiac Dimensions, a leader in transcatheter therapies for heart failure, today announced the publication of three major manuscripts that together form the most comprehensive evidence base ever assembled for transcatheter indirect mitral annuloplasty. These publications span a five-year multi-center commercial registry, the largest single-center experience across both preserved and reduced ejection fraction, and long-term survival results through ten years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707656796/en/ Carillon Mitral Contour System® The Carillon Mitral Contour System is the only commercially available indirect mitral annuloplasty device, designed to treat a broad and expanding population of patients living with functional mitral regurgitation. The newly published data further strengthen the clinical foundation for the therapy as Cardiac Dimensions advances toward regulatory submissions in the United State

First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press Release

Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618626815/en/ First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders Of the 58 participants enrolled,

Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press Release

Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents

Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press Release

Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and smaller, regional community-based networks alike. The financing will scale manufacturing and accelerate commercial deployment, and continue clinical and product development across Leo Cancer Care’s integrated u

LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press Release

The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer of its kind, combining quantum error correction with NISQ qubits. The system will be delivered in 2027, followed by a series of upgrades delivered in multiple phases with an increasing number of logical qubits. The IQM Halocene H4 and the upgraded systems will enable LUMI consortium users, for the first time, to develop and implement Quantum Error Correction (QEC) concepts on a world-leadi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye